{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [["Aged rat", "Frontal cortex", "Histopathology", "Immunohistochemistry", "Oxidative stress", "Ozone"]], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "31610254", "DateCompleted": {"Year": "2020", "Month": "06", "Day": "10"}, "DateRevised": {"Year": "2020", "Month": "06", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "10", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1016/j.aanat.2019.151428", "S0940-9602(19)30132-3"], "Journal": {"ISSN": "1618-0402", "JournalIssue": {"Volume": "227", "PubDate": {"Year": "2020", "Month": "Jan"}}, "Title": "Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft", "ISOAbbreviation": "Ann Anat"}, "ArticleTitle": "Controlled ozone therapy modulates the neurodegenerative changes in the frontal cortex of the aged albino rat.", "Pagination": {"StartPage": "151428", "MedlinePgn": "151428"}, "Abstract": {"AbstractText": ["Aging is a normal process associated with neurodegenerative changes resulting in decline of cognitive and motor functions. Oxidative stress plays an important role. Controlled ozone (O<sub>3</sub>) therapy has been proved to induce oxidative preconditioning thus reversing oxidative stress. To the best of our knowledge, this research is the first attempt to investigate whether the antioxidant properties of O<sub>3</sub> can ameliorate age-associated structural alterations of the cerebral cortex. Ozone administration (at a dose of 0.7mg/kg intraperitonially, three times a week for eight weeks) produced significant downregulation of tissue malondialdehyde (MDA) and upregulation of glutathione, superoxide dismutase (SOD) and catalase (CAT) within the frontal cortex of aged rats. Sections of the frontal cortex from adult and aged rats were stained with hematoxylin and eosin and analyzed using light microscopy. In addition, quantitative immunohistochemical assessments of the expression of inducible nitric oxide synthase (iNOS), caspase-3, glial fibrillary acidic protein (GFAP), Ki67 and acetylcholinesterase (AChE) were performed. Our results revealed the beneficial effect of O<sub>3</sub> in improving the neurodegenerative changes of the cerebral cortex of aged rats. Moreover, this study clarified that O<sub>3</sub> exerted its effects via reducing oxidative stress, apoptosis, gliosis as well as improving neurogenesis and cholinergic plasticity. This work added to the previously proved aging - associated neurodegenerative effects and provided a new insight into the promising role of O<sub>3</sub> to ameliorate these effects."], "CopyrightInformation": "Copyright \u00a9 2019 Elsevier GmbH. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy and Embryology, Faculty of Medicine, Menoufia University, Menoufia, Egypt."}], "Identifier": [], "LastName": "El-Mehi", "ForeName": "Abeer E", "Initials": "AE"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy and Embryology, Faculty of Medicine, Menoufia University, Menoufia, Egypt. Electronic address: manarfaried@med.menofia.edu.eg."}], "Identifier": [], "LastName": "Faried", "ForeName": "Manar A", "Initials": "MA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Ann Anat", "NlmUniqueID": "100963897", "ISSNLinking": "0940-9602"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "GFAP protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Glial Fibrillary Acidic Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Ki-67 Antigen"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 1.11.1.6", "NameOfSubstance": "Catalase"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}], "MeshHeadingList": [{"QualifierName": ["pathology"], "DescriptorName": "Aging"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 3"}, {"QualifierName": ["analysis"], "DescriptorName": "Catalase"}, {"QualifierName": [], "DescriptorName": "Down-Regulation"}, {"QualifierName": ["chemistry", "enzymology", "pathology"], "DescriptorName": "Frontal Lobe"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glial Fibrillary Acidic Protein"}, {"QualifierName": ["analysis"], "DescriptorName": "Glutathione"}, {"QualifierName": [], "DescriptorName": "Immunohistochemistry"}, {"QualifierName": ["metabolism"], "DescriptorName": "Ki-67 Antigen"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["analysis"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["metabolism", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["analysis"], "DescriptorName": "Superoxide Dismutase"}, {"QualifierName": [], "DescriptorName": "Up-Regulation"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "1", "Day": "16"}, {"Year": "2019", "Month": "8", "Day": "2"}, {"Year": "2019", "Month": "9", "Day": "20"}, {"Year": "2019", "Month": "10", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "15", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31610254", "10.1016/j.aanat.2019.151428", "S0940-9602(19)30132-3"]}}]}